ExL Pharma’s 6th Proactive GCP Compliance, taking place March 24-25, 2015, moves to Philadelphia’s Wyndham Philadelphia Historic District. This interactive forum continues to act as the annual gathering for senior-level clinical quality and clinical operations executives to learn, network and discuss strategies to achieve and maintain global GCP compliance. Join us to learn how to effectively build quality risk management approaches into your clinical operations to optimize research, maintain GCP compliance, contain costs and ensure patient safety.
“The 5th Annual GCP Compliance conference delivered on all fronts. The speakers and attendees were knowledgeable and many were influencers or directors of strategy in their respective organizations. The mixed format (talks, workshops, panels, roundtables) kept us all engaged and afforded excellent opportunities for the exchange of ideas as well as networking. I hope to be back next year!” – Nicholas Hargaden, President, Algorithm, Inc.
“This was probably the best industry conference I have attended. It was well worth attending and featured many talented speakers who shared their valuable expertise. I learned a great deal.”– Lisa Murphy, Associate Director, R&D Compliance, Biogen Idec
“I found the focus on risk management to be so relevant. It was great to hear how other companies are managing the process; how they approached it, lessons learned and change management. I also realized many of us are facing the same issues and I walked away with new relationships knowing I could pick up the phone and find out how other’s “risk management journey” was progressing while still able to maintain company confidentialities. Will definitely try to attend next year.” Eva DeMartin, Director, Global Compliance and Training, Allergan
“I found the conference offered a great balance of presentations, workshops, panel and roundtable discussions, attended by and facilitated by such a talented group of experts – for me that was a winning combination!” – Anne Varker, Associate Director, Clinical Quality Assurance, Boehringer Ingelheim Pharmaceuticals, Inc.
“Really good discussions and presentations of where the industry is heading in the future.” – Frances DeGennaro-Culver, Director, Clinical Research, Global Clinical Quality Management, Merck
Professionals from pharma, biotech and medical device companies; CROs; and other clinical trial service providers whose responsibilities involve the following:
This conference is also relevant to clinical QA, compliance and operations professionals from: